{Reference Type}: Case Reports
{Title}: Focal Seizures in a Child Receiving Terbutaline Sulfate: A Case Report.
{Author}: Nadeem F;Ali M;Hameed N;
{Journal}: Cureus
{Volume}: 15
{Issue}: 8
{Year}: 2023 Aug
暂无{DOI}: 10.7759/cureus.43540
{Abstract}: Terbutaline sulfate is a beta-adrenergic receptor agonist. More specific for B2 receptors, it is used as a bronchodilator in asthma. Its known side effects can include dizziness, tremors, and tachycardia. However, seizures are not among the commonly reported side effects. This is the case of a five-month-old girl who presented with focal seizures after the intake of terbutaline sulfate syrup. Other causes of the seizures were excluded through history and investigations, including an EEG and electrolyte panel. The seizures stopped on cessation of the terbutaline sulfate with no recurrence, leading us to believe that the focal seizures were an adverse effect of the terbutaline sulfate. A high index of suspicion for drug-related adverse effects should therefore be kept for a child with new onset focal seizures.